Use of cyclic bioisosters of purine system derivatives for treating diseases produced by disorders of niterergic and dopaminergic systems
The invention relates to application of compounds having a general structural formula: where R= Li, Na, K, R1=-H, -NH2, -Br, -Cl, -OH, -COOH, B=-N , -CH , Z=-CH , -N , A=-N at B=-N , Z=-CH-, A=-CH at B=-N , Z=-CH-, A=-CH at B=-N , Z=-N , A=-CH at B=-CH , Z=-CH , A=-CH at B=-CH , Z=-N , and/or their...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to application of compounds having a general structural formula: where R= Li, Na, K, R1=-H, -NH2, -Br, -Cl, -OH, -COOH, B=-N , -CH , Z=-CH , -N , A=-N at B=-N , Z=-CH-, A=-CH at B=-N , Z=-CH-, A=-CH at B=-N , Z=-N , A=-CH at B=-CH , Z=-CH , A=-CH at B=-CH , Z=-N , and/or their pharmacologically acceptable salts as an active ingredient having appropriate activity with respect to nitrergic and/or dopaminergic systems, in a pharmaceutical composition as neuroprotector for improvement of the cognitive function and for normalization of psychophysiological status, as well as for treatment of a wide spectrum of psychological diseases, cardiovascular diseases, diseases caused by substance abuse, and diseases caused by a hyperactive immune system in mammals including human beings. |
---|